The results of immunohistochemistry and WB showed that CTLA-4, CD80, and CD86 were higher in the HCC and SD-HCC groups than in the other groups, and it was significantly higher in the SD-HCC group. The gene discussed is CTLA4; the disease is hepatocellular carcinoma.